Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-30

FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Clozapine by Mylan Pharmaceuticals, updating labeling for the generic antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)